Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation

Published:2015-09 Issue:5 Volume:16 Page:e101-e104
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Jenkins Russell W.,Oxnard Geoffrey R.,Elkin Sheryl,Sullivan E. Kelly,Carter Jennifer L.,Barbie David A.

Funder

US National Institutes of Health

Uniting Against Lung Cancer

GTM Fund for Lung Cancer Research

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Molecular cloning of a new transforming gene from a chemically transformed human cell line;Cooper;Nature,1984

2. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET;Naldini;Oncogene,1991

3. MET signalling: principles and functions in development, organ regeneration and cancer;Trusolino;Nat Rev Mol Cell Biol,2010

4. Scatter factor/hepatocyte growth factor is essential for liver development;Schmidt;Nature,1995

5. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor;Uehara;Nature,1995

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment;International Journal of Molecular Sciences;2024-08-22

2. Physiologically driven nanodrug delivery system for targeted lung cancer treatment;Exploration of Medicine;2024-04-25

3. Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report;AME Case Reports;2024-04

4. Ensartinib is effective in the treatment of advanced non-small-cell lung cancer with MET amplification after multi-line ALK-TKIs resistance: a case report;Anti-Cancer Drugs;2023-12-13

5. Exploring marine-derived compounds for MET signalling pathway inhibition in cancer: integrating virtual screening, ADME profiling and molecular dynamics investigations;SAR and QSAR in Environmental Research;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3